Science Explorer Back to mapMap
Discussion
Company · Cheonan · South Korea

Genbody (South Korea)

genbody.co.kr/html/main.htmlROR OpenAlex
Research works
8
▼ 70% vs 2018-21
Citations
97
12.8 per fractional work
Top-10% rate
2.7%
all institutions 10.0%
Open access
82%
world 40%
International
26%
world 18%
Genbody (South Korea)

Not ranked overall: Genbody (South Korea) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Genbody (South Korea) work in?

In all years, 67% of research at Genbody (South Korea) is in Health Sciences, 27% in Life Sciences. Its largest fields are Medicine (65%), Immunology and Microbiology (17%), Biochemistry, Genetics and Molecular Biology (9%). It does 1.7× the world's share of Health Sciences.

Health Sciences: 5 fractional works · 67.3% of its workMedicine: 5 fractional works · 65.3% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 20.0% of its workInfectious Diseases: 1 fractional works · 16.1% of its workEpidemiology: 1 fractional works · 8.3% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 6.2% of its workDermatology: 0 fractional works · 3.3% of its workPhysiology: 0 fractional works · 3.3% of its workRehabilitation: 0 fractional works · 3.3% of its workSurgery: 0 fractional works · 2.6% of its workOncology: 0 fractional works · 1.3% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.9% of its workHealth Professions: 0 fractional works · 2.0% of its workPhysical Therapy, Sports Therapy and Rehabilitation: 0 fractional works · 1.1% of its workPharmacy: 0 fractional works · 0.9% of its workLife Sciences: 2 fractional works · 26.7% of its workImmunology and Microbiology: 1 fractional works · 16.7% of its workParasitology: 1 fractional works · 13.4% of its workImmunology: 0 fractional works · 2.2% of its workVirology: 0 fractional works · 1.1% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 8.6% of its workMolecular Biology: 1 fractional works · 7.1% of its workGenetics: 0 fractional works · 1.5% of its workAgricultural and Biological Sciences: 0 fractional works · 1.5% of its workAnimal Science and Zoology: 0 fractional works · 1.5% of its workPhysical Sciences: 0 fractional works · 6.0% of its workEngineering: 0 fractional works · 5.2% of its workBiomedical Engineering: 0 fractional works · 3.7% of its workElectrical and Electronic Engineering: 0 fractional works · 1.6% of its workComputer Science: 0 fractional works · 0.8% of its workComputational Theory and Mathematics: 0 fractional works · 0.8% of its workALL ITS WORKGenbody (SouthKorea)8fractional works, all years
Life Sciences27%Physical Sciences6%Health Sciences67%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 7 fields, with their numbers
    1. Medicine565.3%
    2. Health Professions02.0%
    1. Immunology and Microbiology116.7%
    2. Biochemistry, Genetics and Molecular Biology18.6%
    3. Agricultural and Biological Sciences01.5%
    1. Engineering05.2%
    2. Computer Science00.8%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Genbody (South Korea)?

Ranked on the quality score, Jihoo Lee lead among researchers whose main affiliation is Genbody (South Korea).

  1. 1 Jihoo Lee South Korea · #5,170,687 worldwide 156 citations · 20 works
All ranked researchers at Genbody (South Korea)

What are the most cited papers from Genbody (South Korea)?

The most cited paper from Genbody (South Korea) is "Validation of a wearable cuff-less wristwatch-type blood pressure monitoring device" (Joon Ho Moon, Myung-Kyun Kang, Chang-Eun Choi et al., 2020), with 57 citations. Next come "Effect of herbal mixture composed of Alchemilla vulgaris and Mimosa on wound healing process" (48) and "Development of a smartphone-based rapid dual fluorescent diagnostic system for the simultaneous detection of influenza A and H5 subtype in avian influenza A-infected patients" (35).

Most cited papers
#PaperReleasedCitations
1 Validation of a wearable cuff-less wristwatch-type blood pressure monitoring device Joon Ho Moon, Myung-Kyun Kang, Chang-Eun Choi et al. · Scientific Reports Open access 4 Nov 2020 57
2 Effect of herbal mixture composed of Alchemilla vulgaris and Mimosa on wound healing process Jawun Choi, Yang-Gyu Park, Min-Sang Yun et al. · Biomedicine & Pharmacotherapy 12 Jul 2018 48
3 Development of a smartphone-based rapid dual fluorescent diagnostic system for the simultaneous detection of influenza A and H5 subtype in avian influenza A-infected patients Seon‐Ju Yeo, Homan Kang, Tung Duy Dao et al. · Theranostics Open access 2018 35
4 Development of a Rapid Diagnostic Test Kit to Detect IgG/IgM Antibody against Zika Virus Using Monoclonal Antibodies to the Envelope and Non-structural Protein 1 of the Virus Yeong Hoon Kim, Jihoo Lee, Young‐Eun Kim et al. · Korean Journal of Parasitology Open access 28 Feb 2018 28
5 Development and Clinical Evaluation of an Immunochromatography-Based Rapid Antigen Test (GenBody™ COVAG025) for COVID-19 Diagnosis Doyeong Kim, Jihoo Lee, Jyotiranjan Bal et al. · Viruses Open access 29 Apr 2021 25
All 23 most cited papers, with filters and sorting

Which research topics does Genbody (South Korea) publish most on?

By volume in 2022-now: Non-Invasive Vital Sign Monitoring, Blood Pressure and Hypertension Studies, Heart Rate Variability and Autonomic Control and Animal Virus Infections Studies.

Non-Invasive Vital Sign Monitoring: 0 fractional worksBlood Pressure and Hypertension Studies: 0 fractional worksHeart Rate Variability and Autonomic Control: 0 fractional worksAnimal Virus Infections Studies: 0 fractional worksParvovirus B19 Infection Studies: 0 fractional worksVirus-based gene therapy…0Virus-based gene therapy research: 0 fractional worksLymphatic Disorders and Treatments: 0 fractional worksLymphatic System and Diseases: 0 fractional worksBody Composition Measure…0Body Composition Measurement Techniques: 0 fractional works
Biomedical EngineeringCardiology and Cardiovascular MedicineAnimal Science and ZoologyInfectious Diseases4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Non-Invasive Vital Sign Monitoring Biomedical Engineering 0 works
  2. 2 Blood Pressure and Hypertension Studies Cardiology and Cardiovascular Medicine 0 works
  3. 3 Heart Rate Variability and Autonomic Control Cardiology and Cardiovascular Medicine 0 works
  4. 4 Animal Virus Infections Studies Animal Science and Zoology 0 works
  5. 5 Parvovirus B19 Infection Studies Infectious Diseases 0 works
  6. 6 Virus-based gene therapy research Genetics 0 works
  7. 7 Lymphatic Disorders and Treatments Surgery 0 works
  8. 8 Lymphatic System and Diseases Oncology 0 works
  9. 9 Body Composition Measurement Techniques Physiology 0 works
  10. 10 Electrical and Bioimpedance Tomography Electrical and Electronic Engineering 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available82.0%not open18.0%

World: 40% of research is openly available.

with international co-authors25.7%domestic only74.3%

World: 18% is written across borders.

How has Genbody (South Korea)'s research output changed?

Output in 2022-2025 was 70% lower than in 2018-2021.

still counting201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Genbody (South Korea) as a percentage of every work published that year, 0.0000061% in 2023.

still counting0.000020%0.000040%Genbody (South Korea)0.0000034% in 20252020

Fractional works of Genbody (South Korea) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Cheonan

All research institutions in Cheonan

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Genbody (South Korea). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.